Merck Ltd. | Income Statement

Fiscal year is January-December. All values INR Millions.
2013
2014
2015
2016
2017
Sales/Revenue
7,943
8,654
9,375
9,919
11,035
Cost of Goods Sold (COGS) incl. D&A
5,269
5,868
6,425
6,492
7,125
Gross Income
2,674
2,786
2,950
3,427
3,910
SG&A Expense
1,951
2,041
2,275
2,308
2,570
EBIT
634
442
620
-
1,298
Unusual Expense
-
-
-
85
172
Non Operating Income/Expense
67
59
59
49
219
Pretax Income
883
666
833
1,152
1,522
Income Tax
324
233
298
360
583
Consolidated Net Income
559
432
536
791
939
Net Income
559
432
536
791
939
Net Income After Extraordinaries
559
432
536
791
939
Net Income Available to Common
559
432
536
791
939
EPS (Basic)
33.70
26.00
32.30
47.70
56.60
Basic Shares Outstanding
17
17
17
17
17
EPS (Diluted)
33.66
26.04
32.27
47.67
56.57
Diluted Shares Outstanding
17
17
17
17
17
EBITDA
735
569
854
1,259
1,562
Other Operating Expense
89
303
55
108
42
Non-Operating Interest Income
181
165
155
177
177

About Merck

View Profile
Address
Godrej One, 8th Floor, Pirojshanagar
Mumbai Maharashtra 400079
India
Employees -
Website http://www.merck.co.in
Updated 09/14/2018
Merck (India) Ltd. engages in the business of manufacturing and marketing of pharmaceuticals and chemicals. It operates through the Pharmaceuticals and Chemicals segment. The Pharmaceutical segment comprises of products used in the treatment of cardiovascular and metabolic diseases, consumer healthcare products and vitamins-based formulations.